Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

33.84 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income 128.853181.46834.597-36.944-151.977-39.898
Depreciation & Amortization 24.35923.38518.8410.2373.210.184
Deferred Income Tax -13.419-85.94326.14625.74800
Stock Based Compensation 31.70526.17315.6594.6939.9091.079
Change In Working Capital 35.035-4.1060.631-11.6288.292-0.164
Accounts Receivables -19.4-19.897-12.667-17.922-4.2550
Inventory -1.0660.135-0.609-2.735-1.0880
Accounts Payables 8.9492.785-1.555-3.8044.898-0.61
Other Working Capital 46.55212.87115.46212.8338.7370.446
Other Non Cash Items 12.8543.4892.6844.90955.132.057
Operating Cash Flow 219.387144.46698.557-2.985-75.436-38.799
Investing Activities:
Investments In Property Plant And Equipment -0.312-40.172-100.298-2.002-127.149-1.342
Acquisitions Net -36.967141.832-100-2-520
Purchases Of Investments -127.469-110.7290000
Sales Maturities Of Investments 118.3099.0690000
Other Investing Activites 0-141.8321002520
Investing Cash Flow -46.439-141.832-100.298-2.002-127.149-1.342
Financing Activities:
Debt Repayment -1.25-2-0.579.4151000
Common Stock Issued 08.84130147.62850.0850
Common Stock Repurchased -10000-0.167-1.132-3.2
Dividends Paid 000000
Other Financing Activities -4.3028.841-22.081-17.71593.76924.815
Financing Cash Flow -105.5526.8417.419209.161143.76921.615
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 67.3969.4755.678204.174-58.816-18.526
Cash At End Of Period 311.93244.534235.059229.38125.20784.023